tiprankstipranks
Advertisement
Advertisement

HK:2197 Stock Latest News

Clover Biopharmaceuticals Signals Interim Profit on One-Off Gavi Settlement Gain
Company AnnouncementsClover Biopharmaceuticals Signals Interim Profit on One-Off Gavi Settlement Gain
18d ago
2197
Clover Biopharmaceuticals Wins Shareholder Backing for All AGM Resolutions
PremiumCompany Announcements
Clover Biopharmaceuticals Wins Shareholder Backing for All AGM Resolutions
2M ago
2197
Clover Biopharmaceuticals Tightens Insider Trading Compliance After Governance Review
PremiumCompany Announcements
Clover Biopharmaceuticals Tightens Insider Trading Compliance After Governance Review
2M ago
2197
Clover Biopharmaceuticals Sets 2026 AGM to Renew Board Mandates and Share Issuance Authority
PremiumCompany Announcements
Clover Biopharmaceuticals Sets 2026 AGM to Renew Board Mandates and Share Issuance Authority
2M ago
2197
Clover Biopharmaceuticals Details Capped Payment Deal With Gavi, Easing US$224 Million Exposure
PremiumCompany Announcements
Clover Biopharmaceuticals Details Capped Payment Deal With Gavi, Easing US$224 Million Exposure
4M ago
2197
Clover Biopharmaceuticals Completes Enrollment in Phase 2 Trial for Combination Respiratory Vaccines
PremiumCompany AnnouncementsClover Biopharmaceuticals Completes Enrollment in Phase 2 Trial for Combination Respiratory Vaccines
4M ago
2197
Clover Biopharmaceuticals Grants Over 19 Million Equity Awards to Align Pay With Performance
Premium
Company Announcements
Clover Biopharmaceuticals Grants Over 19 Million Equity Awards to Align Pay With Performance
4M ago
2197
Clover Narrows Loss as It Cuts Costs and Refocuses on Respiratory Vaccines
Premium
Company Announcements
Clover Narrows Loss as It Cuts Costs and Refocuses on Respiratory Vaccines
4M ago
2197
Clover posts strong RSV re-vaccination data in head-to-head trial with GSK
PremiumCompany Announcements
Clover posts strong RSV re-vaccination data in head-to-head trial with GSK
4M ago
2197
Clover Biopharmaceuticals Strikes Cap-Limited Settlement With Gavi to End Arbitration
PremiumCompany Announcements
Clover Biopharmaceuticals Strikes Cap-Limited Settlement With Gavi to End Arbitration
5M ago
2197
Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend
PremiumCompany Announcements
Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend
5M ago
2197
Clover Launches Phase 2 Trial of Combination Respiratory Vaccines in Older Adults
PremiumCompany Announcements
Clover Launches Phase 2 Trial of Combination Respiratory Vaccines in Older Adults
7M ago
2197
Clover Biopharmaceuticals Reports Positive Phase I Results for Respiratory Vaccines
PremiumCompany AnnouncementsClover Biopharmaceuticals Reports Positive Phase I Results for Respiratory Vaccines
10M ago
2197
Clover Biopharmaceuticals Reports Interim Financial Results for 2025
Premium
Company Announcements
Clover Biopharmaceuticals Reports Interim Financial Results for 2025
12M ago
2197
Clover Biopharmaceuticals to Review Interim Financial Results and Dividend Proposal
Premium
Company Announcements
Clover Biopharmaceuticals to Review Interim Financial Results and Dividend Proposal
12M ago
2197
Clover Biopharmaceuticals Announces Board and Committee Changes
PremiumCompany Announcements
Clover Biopharmaceuticals Announces Board and Committee Changes
1y ago
2197
Clover Biopharmaceuticals Strengthens Governance with New Nomination Committee
PremiumCompany Announcements
Clover Biopharmaceuticals Strengthens Governance with New Nomination Committee
1y ago
2197
Clover Biopharmaceuticals Announces Unanimous AGM Results and Director Retirement
PremiumCompany Announcements
Clover Biopharmaceuticals Announces Unanimous AGM Results and Director Retirement
1y ago
2197
Clover Biopharmaceuticals Launches Phase I Trial for New Respiratory Vaccines
PremiumCompany Announcements
Clover Biopharmaceuticals Launches Phase I Trial for New Respiratory Vaccines
1y ago
2197
Clover Biopharmaceuticals Ends Distribution Agreement with Adimmune
PremiumCompany AnnouncementsClover Biopharmaceuticals Ends Distribution Agreement with Adimmune
1y ago
2197
Clover Biopharmaceuticals Faces Arbitration Over $224 Million Claim
Premium
Company Announcements
Clover Biopharmaceuticals Faces Arbitration Over $224 Million Claim
1y ago
2197
Clover Biopharmaceuticals Announces 2025 Annual General Meeting Agenda
Premium
Company Announcements
Clover Biopharmaceuticals Announces 2025 Annual General Meeting Agenda
1y ago
2197

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >